ClinicalTrials.Veeva

Menu

"Short-term Outcome in STEMI Patients Undergoing Primary PCI: A Comparative Study Between Rural and Urban Communities at Assiut University."

A

Assiut University

Status

Not yet enrolling

Conditions

MACE
In STEMI

Treatments

Device: Primary Percutaneous Coronary Intervention (PPCI)

Study type

Observational

Funder types

Other

Identifiers

NCT07136831
STEMI-PPCI-RURALURBAN-ASU25

Details and patient eligibility

About

this study aims to assess the short-term (3-month) clinical and echocardiographic outcomes of primary PCI among STEMI patients from rural versus urban areas in Upper Egypt. A special focus will be placed on identifying predictors of MACE. The findings may offer valuable insight into optimizing STEMI care pathways and support the development of regional STEMI networks across Egypt.

Full description

ST-segment elevation myocardial infarction (STEMI) is a life-threatening condition that requires urgent reperfusion therapy, with primary percutaneous coronary intervention (PCI) being the gold standard of care. While PCI significantly reduces complications and improves survival, access to this intervention remains unequal, particularly between rural and urban populations

According to the latest census definitions, a rural area is characterized by:A population of fewer than 5,000,A population density of less than 400 persons per square kilometer,And more than 25% of the male working population engaged in agriculture.

Rural patients often experience delayed diagnosis, limited access to PCI-capable centers, and prolonged ischemic times. These factors contribute to poorer clinical outcomes, including higher rates of reinfarction, heart failure, and mortality. In contrast, urban residents typically have faster access to specialized cardiac care and more efficient treatment pathways.

In Upper Egypt, this urban-rural gap is particularly pronounced, with rural patients facing substantial logistical and systemic challenges in receiving timely PCI. Although efforts have been made to expand PCI access nationwide, there remains a lack of localized data comparing short-term outcomes-particularly major adverse cardiovascular events (MACE)-between rural and urban STEMI patients.

Enrollment

162 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

    1. Adults aged ≥18 years. 2. Confirmed diagnosis of ST-segment elevation myocardial infarction (STEMI) based on ECG and cardiac biomarkers.

    2. Underwent primary percutaneous coronary intervention (PCI) within the study period.

    3. Known and verified residential address classified as rural or urban based on official definitions (e.g., UK or WHO classification).

    4. Informed consent obtained

Exclusion criteria

  1. Non-STEMI or unstable angina cases.

  2. Patients who received fibrinolytic therapy instead of PCI.

  3. Transfer from another facility after more than 12 hours of symptom onset.

  4. Patients with previous revascularization (e.g., CABG or PCI within the last 6 months).

  5. Incomplete clinical data or unknown residential location.

Trial contacts and locations

0

Loading...

Central trial contact

Hatem Abdelrahman, Professor; Fatma ali khallaf Dr fatma ali

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems